These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12558676)

  • 21. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternaria simulating metastatic breast carcinoma in cytokeratin-stained axillary sentinel node sections.
    Robinson BD; Amin BD; Hoda SA
    Breast J; 2008; 14(1):120-1. PubMed ID: 18186881
    [No Abstract]   [Full Text] [Related]  

  • 23. The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer.
    McMasters KM
    Ann Surg Oncol; 2003 Dec; 10(10):1128-30. PubMed ID: 14654464
    [No Abstract]   [Full Text] [Related]  

  • 24. Positive sentinel lymph node: New controversies regarding axillary node dissection.
    Rubio IT
    J Surg Oncol; 2006 Jun; 93(7):517-8. PubMed ID: 16705727
    [No Abstract]   [Full Text] [Related]  

  • 25. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.
    Cady B
    J Surg Oncol; 2001 Jul; 77(3):149-52. PubMed ID: 11455549
    [No Abstract]   [Full Text] [Related]  

  • 26. Axillary recurrence of breast cancer following negative sentinel lymph node biopsy and axillary clearance.
    Cserni G
    Eur J Surg Oncol; 2000 Sep; 26(6):629. PubMed ID: 11034819
    [No Abstract]   [Full Text] [Related]  

  • 27. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservative Management of Positive Axilla After Neoadjuvant Systemic Therapy-The Need for, and Review of, Techniques Used for Lymph Node Localization.
    Green M; Neamonitou F; Vidya R
    Clin Breast Cancer; 2018 Oct; 18(5):e739-e742. PubMed ID: 29983380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel nodes outside level I-II of the axilla and staging in breast cancer.
    Rönka R; Krogerus L; Leppänen E; Smitten KV; Leidenius M
    Anticancer Res; 2002; 22(5):3109-12. PubMed ID: 12530052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
    Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
    Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
    Cserni G
    Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An axillary score (Barranger Score) to predict nonsentinel node metastasis in breast cancer patients with positive sentinel node.
    Coutant C; Uzan S; Morel O; Malartic C; Akerman G; Barranger E
    Am J Surg; 2008 Jan; 195(1):135-6. PubMed ID: 18070736
    [No Abstract]   [Full Text] [Related]  

  • 34. Atypical endosalpingiosis in axillary sentinel lymph node: a potential source of false-positive diagnosis of metastasis.
    Sarode VR; Euhus D; Thompson M; Peng Y
    Breast J; 2011; 17(6):672-3. PubMed ID: 21951608
    [No Abstract]   [Full Text] [Related]  

  • 35. Internal mammary sentinel lymph node biopsy should still be performed, especially in the patient with clinically positive axillary lymph nodes.
    Qiu PF; Zhao RR; Liu YB; Wang YS
    Breast; 2013 Oct; 22(5):999-1000. PubMed ID: 23838319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer.
    Mullenix PS; Carter PL; Martin MJ; Steele SR; Scott CL; Walts MJ; Beitler AL
    Am J Surg; 2003 May; 185(5):420-4. PubMed ID: 12727560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
    Recht A
    Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel node biopsy is not an alternative to axillary dissection in breast cancer.
    Moffat FL
    J Surg Oncol; 2001 Jul; 77(3):153-6. PubMed ID: 11455550
    [No Abstract]   [Full Text] [Related]  

  • 39. Glandular structures in an intraoperative axillary sentinel lymph node biopsy: a diagnostic dilemma.
    Nga ME; Putti TC
    Histopathology; 2006 Mar; 48(4):475-7. PubMed ID: 16487377
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
    van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K
    Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.